BR0107954A - Inibidores duplos de sìntese de éster de colesterol e éster de cera para distúrbios de glândula sebácea - Google Patents
Inibidores duplos de sìntese de éster de colesterol e éster de cera para distúrbios de glândula sebáceaInfo
- Publication number
- BR0107954A BR0107954A BR0107954-9A BR0107954A BR0107954A BR 0107954 A BR0107954 A BR 0107954A BR 0107954 A BR0107954 A BR 0107954A BR 0107954 A BR0107954 A BR 0107954A
- Authority
- BR
- Brazil
- Prior art keywords
- acne
- sebaceous gland
- ester
- gland disorders
- synthesis inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"INIBIDORES DUPLOS DE SìNTESE DE éSTER DE COLESTEROL E éSTER DE CERA PARA DISTúRBIOS DE GLâNDULA SEBáCEA". A presente invenção fornece um método de tratamento de distúrbios de glândula sebácea compreendendo administrar a um paciente em necessidade do referido tratamento uma quantidade eficaz de um composto denominado éster de 2,6-diisopropil-fenila de ácido [(2,4,6-triisopropilfenil)-acetil]-sulfâmico ou um sal farmaceuticamente aceitável deste. Particularmente, os métodos de tratamento de distúrbios da glândula sebácea são fornecidos quando os referidos distúrbios são selecionados de seborréia, acnes, tais como, por exemplo, a cloracne, a acne ciliar, a acne cística, a acne ceratosa, a acne simples, a acne senil, e a acne medicinal.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17977800P | 2000-02-02 | 2000-02-02 | |
| PCT/US2001/002190 WO2001056556A2 (en) | 2000-02-02 | 2001-01-23 | Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0107954A true BR0107954A (pt) | 2002-10-22 |
Family
ID=22657957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0107954-9A BR0107954A (pt) | 2000-02-02 | 2001-01-23 | Inibidores duplos de sìntese de éster de colesterol e éster de cera para distúrbios de glândula sebácea |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6730703B2 (pt) |
| EP (1) | EP1263421B1 (pt) |
| JP (1) | JP2003531113A (pt) |
| KR (1) | KR20020073574A (pt) |
| CN (1) | CN1398182A (pt) |
| AP (1) | AP2002002612A0 (pt) |
| AT (1) | ATE295724T1 (pt) |
| AU (1) | AU781563B2 (pt) |
| BG (1) | BG107042A (pt) |
| BR (1) | BR0107954A (pt) |
| CA (1) | CA2398219A1 (pt) |
| CR (1) | CR6712A (pt) |
| DE (1) | DE60110897T2 (pt) |
| DZ (1) | DZ3288A1 (pt) |
| EA (1) | EA004255B1 (pt) |
| EE (1) | EE200200429A (pt) |
| ES (1) | ES2239145T3 (pt) |
| GE (1) | GEP20043286B (pt) |
| HR (1) | HRP20020717A2 (pt) |
| HU (1) | HUP0301010A3 (pt) |
| IL (1) | IL150865A0 (pt) |
| IS (1) | IS6478A (pt) |
| MA (1) | MA26872A1 (pt) |
| MX (1) | MXPA02007309A (pt) |
| NO (1) | NO20023659L (pt) |
| NZ (1) | NZ520330A (pt) |
| OA (1) | OA12173A (pt) |
| PL (1) | PL357041A1 (pt) |
| PT (1) | PT1263421E (pt) |
| SK (1) | SK10972002A3 (pt) |
| UA (1) | UA75345C2 (pt) |
| WO (1) | WO2001056556A2 (pt) |
| YU (1) | YU57502A (pt) |
| ZA (1) | ZA200206075B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1281399A3 (en) * | 2001-08-01 | 2004-02-11 | Warner-Lambert Company | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production |
| US20050031699A1 (en) | 2003-06-26 | 2005-02-10 | L'oreal | Porous particles loaded with cosmetically or pharmaceutically active compounds |
| ATE409470T1 (de) | 2003-10-09 | 2008-10-15 | Warner Lambert Co | Pharmazeutische zusammensetzungen mit malonamid- derivaten zur verringerung der talg-produktion |
| KR100906288B1 (ko) | 2005-02-24 | 2009-07-06 | 워너-램버트 캄파니 엘엘씨 | 결정질 ａｃａｔ 억제제 |
| FR2904002A1 (fr) * | 2006-07-19 | 2008-01-25 | Galderma Res & Dev S N C Snc | Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee |
| FR2903999B1 (fr) * | 2006-07-19 | 2008-09-05 | Galderma Res & Dev S N C Snc | Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee |
| FR2938342A1 (fr) * | 2008-11-13 | 2010-05-14 | Galderma Res & Dev | Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee |
| CA2750233A1 (en) | 2009-01-28 | 2010-08-05 | Nanobio Corporation | Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof |
| JP2021527634A (ja) * | 2018-06-21 | 2021-10-14 | デルマバント サイエンシズ ゲーエムベーハー | Ｄｇａｔ１阻害剤の局所製剤およびそれらの使用の方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4545977A (en) * | 1985-01-11 | 1985-10-08 | G. D. Searle & Co. | Compositions and methods for treating severe acne with isotretinoin |
| US4751026A (en) | 1986-03-24 | 1988-06-14 | Warner-Lambert Company | Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase |
| US4722927A (en) | 1986-04-28 | 1988-02-02 | Warner-Lambert Company | Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase |
| EP0252524A3 (en) | 1986-07-11 | 1989-04-19 | Warner-Lambert Company | Aryl- and aralkylamide- derivatives of omega- (substituted-phenyloxy)-alkanoic acids as inhibitors of acyl-coa: cholesterol acyltransferase and pharmaceuticals containing them |
| US4716175A (en) | 1987-02-24 | 1987-12-29 | Warner-Lambert Company | Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase |
| IE61716B1 (en) | 1987-06-02 | 1994-11-30 | Warner Lambert Co | Antihyperlipidemic and antiatherosclerotic urea compounds |
| US5015644A (en) | 1987-06-02 | 1991-05-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
| EP0297610B1 (en) | 1987-07-02 | 1991-03-13 | Warner-Lambert Company | N-[(2,6-disubstituted)phenyl]-urea and carbamate inhibitors of acyl-CoA:cholesterol acyl-transferase |
| US5116848A (en) | 1988-03-30 | 1992-05-26 | Warner-Lambert Company | N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents |
| US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US4948806A (en) | 1988-03-30 | 1990-08-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US5030653A (en) | 1988-03-30 | 1991-07-09 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US4999373A (en) | 1988-03-30 | 1991-03-12 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US4923896A (en) | 1989-02-09 | 1990-05-08 | Warner-Lambert Company | N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
| US5155127A (en) | 1989-02-09 | 1992-10-13 | Warner-Lambert Company | N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
| US4994465A (en) | 1989-02-17 | 1991-02-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds |
| AU632809B2 (en) | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
| CA2022346A1 (en) | 1989-08-04 | 1991-02-05 | Mitsubishi Chemical Corporation | 1-phenylalkyl-3-phenylurea derivatives |
| WO1991004027A1 (en) | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| TW205037B (pt) | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd | |
| JPH05310678A (ja) | 1990-01-22 | 1993-11-22 | Mitsubishi Kasei Corp | １−フェニルアルキル−３−フェニル尿素誘導体 |
| US5362878A (en) | 1991-03-21 | 1994-11-08 | Pfizer Inc. | Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) |
| ES2125325T3 (es) | 1992-01-23 | 1999-03-01 | Pfizer | Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos. |
| CA2134359C (en) | 1992-05-28 | 1997-07-01 | Ernest S. Hamanaka | New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| US5565472A (en) | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| US5596001A (en) | 1993-10-25 | 1997-01-21 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)quinoline derivatves |
| US5494172A (en) * | 1994-05-12 | 1996-02-27 | Miller Compressing Company | Magnetic pulley assembly |
| US6133326A (en) | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
| EP1090014B1 (en) * | 1998-06-25 | 2003-09-03 | Tularik Inc. | Arylsulfonanilide phosphates |
| PE20020453A1 (es) * | 2000-09-27 | 2002-06-06 | Merck & Co Inc | Derivados del acido benzopirancarboxilico para el tratamiento de la diabetes y los trastornos de lipidos |
-
2001
- 2001-01-23 KR KR1020027009943A patent/KR20020073574A/ko not_active Application Discontinuation
- 2001-01-23 AT AT01948936T patent/ATE295724T1/de not_active IP Right Cessation
- 2001-01-23 PT PT01948936T patent/PT1263421E/pt unknown
- 2001-01-23 CN CN01804520A patent/CN1398182A/zh active Pending
- 2001-01-23 OA OA1200200234A patent/OA12173A/en unknown
- 2001-01-23 PL PL01357041A patent/PL357041A1/xx not_active Application Discontinuation
- 2001-01-23 MX MXPA02007309A patent/MXPA02007309A/es active IP Right Grant
- 2001-01-23 HU HU0301010A patent/HUP0301010A3/hu unknown
- 2001-01-23 BR BR0107954-9A patent/BR0107954A/pt not_active Application Discontinuation
- 2001-01-23 JP JP2001556248A patent/JP2003531113A/ja active Pending
- 2001-01-23 GE GEAP20016597A patent/GEP20043286B/en unknown
- 2001-01-23 SK SK1097-2002A patent/SK10972002A3/sk not_active Application Discontinuation
- 2001-01-23 EP EP01948936A patent/EP1263421B1/en not_active Expired - Lifetime
- 2001-01-23 DE DE60110897T patent/DE60110897T2/de not_active Expired - Fee Related
- 2001-01-23 NZ NZ520330A patent/NZ520330A/en unknown
- 2001-01-23 EE EEP200200429A patent/EE200200429A/xx unknown
- 2001-01-23 AU AU29718/01A patent/AU781563B2/en not_active Ceased
- 2001-01-23 CA CA002398219A patent/CA2398219A1/en not_active Abandoned
- 2001-01-23 UA UA2002076160A patent/UA75345C2/uk unknown
- 2001-01-23 ES ES01948936T patent/ES2239145T3/es not_active Expired - Lifetime
- 2001-01-23 DZ DZ013288A patent/DZ3288A1/fr active
- 2001-01-23 EA EA200200764A patent/EA004255B1/ru not_active IP Right Cessation
- 2001-01-23 WO PCT/US2001/002190 patent/WO2001056556A2/en active IP Right Grant
- 2001-01-23 US US10/182,847 patent/US6730703B2/en not_active Expired - Fee Related
- 2001-01-23 AP APAP/P/2002/002612A patent/AP2002002612A0/en unknown
- 2001-01-23 IL IL15086501A patent/IL150865A0/xx unknown
- 2001-01-23 YU YU57502A patent/YU57502A/sh unknown
-
2002
- 2002-07-19 IS IS6478A patent/IS6478A/is unknown
- 2002-07-24 CR CR6712A patent/CR6712A/es not_active Application Discontinuation
- 2002-07-30 ZA ZA200206075A patent/ZA200206075B/en unknown
- 2002-08-01 MA MA26756A patent/MA26872A1/fr unknown
- 2002-08-01 NO NO20023659A patent/NO20023659L/no not_active Application Discontinuation
- 2002-08-29 BG BG107042A patent/BG107042A/bg unknown
- 2002-08-30 HR HR20020717A patent/HRP20020717A2/hr not_active Application Discontinuation
-
2004
- 2004-02-06 US US10/773,354 patent/US20040161393A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1110302C (zh) | 治疗皮肤病况的含氧酸及相关化合物 | |
| CN1143668C (zh) | 抗坏血酸基-磷酰基-胆固醇 | |
| US20060120980A1 (en) | Novel dermatological composition using bio-activating organocatalysts | |
| EE05025B1 (et) | Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks | |
| JP2002521320A (ja) | 皮膚の脂質産生、バリア機能、過酸化水素中和、および保湿を促進するための組成物 | |
| BR0009043A (pt) | Composto, composição farmacêutica, e, método de tratar uma doença em um animal em que a atividade da cisteìna protease contribui para a patologia e/ou sintomatologia da doença | |
| CN105792810A (zh) | 用于表皮修复的配方 | |
| HUP9701540A1 (hu) | A gasztrointesztinális keringést elősegítő gyógyászati készítmény | |
| ES2114616T5 (es) | Acidos dicarboxilicos alifaticos insaturados. | |
| RU94040170A (ru) | Изохинолины | |
| CA2157142A1 (en) | Treatment of diseases caused by sebaceous gland disorders | |
| PT93935A (pt) | Processo para a preparacao de uma composicao farmaceutica para o tratamento topico de acne vulgar contendo cetoconazol | |
| BR0313630A (pt) | Composição para aplicação tópica, sistema para o tratamento de caspa, métodos para o tratamento e/ou prevenção da caspa e da coceira do couro cabeludo e usos de uma combinação sinérgica | |
| ATE336997T1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
| MY137435A (en) | Retinoid compounds (i) | |
| DE59608698D1 (de) | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure | |
| BR0107954A (pt) | Inibidores duplos de sìntese de éster de colesterol e éster de cera para distúrbios de glândula sebácea | |
| GB2210789A (en) | Topical application for skin care | |
| CZ63295A3 (en) | 1 alpha-fluoro-25-hydroxy-16-en-23-in-cholecalciferol as such and for the use as a therapeutic active compound, its use for the preparation of a pharmaceutical preparation, process of its preparation and a pharmaceutical preparation based thereon | |
| JP2010030927A (ja) | 皮膚外用剤 | |
| DE69434002D1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
| JPH11228338A (ja) | リパーゼ阻害剤及びニキビ改善用外用剤 | |
| KR20240004954A (ko) | 소분자 화합물을 사용하여 여드름-후 위축성 흉터의 외관을 개선하는 방법 (methods of using a small molecule chemical compound to reduce the appearance of post-acne atrophic scarring) | |
| SE9903610D0 (sv) | Novel compounds II | |
| GB8928609D0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INT.CL: A61K 31/00 Ipc: A61K 31/255 (2010.01), A61K 31/18 (2010.01), A61P |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13 E 24 DA LPI |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |